NEOPLASMS,OVARIAN
Clinical trials for NEOPLASMS,OVARIAN explained in plain language.
Never miss a new study
Get alerted when new NEOPLASMS,OVARIAN trials appear
Sign up with your email to follow new studies for NEOPLASMS,OVARIAN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New cancer drug shows promise in early trial
Disease control CompletedThis study tested a new drug called ESG401 in people with advanced solid tumors that had spread or couldn't be removed by surgery. The main goals were to find a safe dose and see if the drug could shrink tumors. The trial included 156 people with various cancers including breast,…
Matched conditions: NEOPLASMS,OVARIAN
Phase: PHASE1, PHASE2 • Sponsor: Shanghai Escugen Biotechnology Co., Ltd • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
New hope for women battling tough ovarian cancer
Disease control CompletedThis study tested a new targeted drug called farletuzumab ecteribulin (MORAb-202) against standard chemotherapy for women with a specific, hard-to-treat form of ovarian cancer that had stopped responding to platinum-based drugs. The goal was to see if the new drug was safer and m…
Matched conditions: NEOPLASMS,OVARIAN
Phase: PHASE2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC